Correction to: Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway

Correction: Adv Rheumatol63, 45 (2023) https://doi.org/10.1186/s42358-023-00325-z

In the original version of this article [¹], the affiliations were published incorrectly.

The correct affiliations are given below:

1. Department of Geriatrics, Chongqing Medical University, Chongqing, 400010, China

2. Department of Geriatrics, Chongqing General Hospital, Chongqing, 400010, China

The affiliations have been updated above and the original article has been corrected.

The publisher would like to apologize for any inconvenience caused.

• Publisher's Note
  Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
• The online version of the original article can be found at https://doi.org/10.1186/s42358-023-00325-z

References

• ¹
  Liu H, Yang Y, Zhang J, et al. Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway. Adv Rheumatol. 2023;63:45. https://doi.org/10.1186/s42358-023-00325-z
  » https://doi.org/10.1186/s42358-023-00325-z

Publication Dates

• Publication in this collection
  30 Oct 2023
• Date of issue
  2023

History

• Published
  06 Sept 2023